See All Slides - tctmd.com

Slides

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Presenter: Koen Keirse

October 29, 2013

Presentation TCT 2013

How Did I Treat This Case?(2)

Presenter: Aylin Hatice Yamac

October 29, 2013

Presentation TCT 2013

TCT-71. The Association Between Tissue Characteristics assessed with Optical Coherence Tomography and Midterm Results After Percutaneous Coronary Intervention for In-stent...

Presenter: Takeshi Tada

October 29, 2013

Presentation TCT 2013

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

Presenter: Bent Raungaard

October 29, 2013

Presentation TCT 2013

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

Presenter: Soo-Jin Kang

October 29, 2013

Presentation TCT 2013

How Would I Treat This Case?

Presenter: Thierry Lefevre

October 29, 2013

Presentation TCT 2013

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Presenter: Julie Logan

October 29, 2013

Presentation TCT 2013

Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada)

Presenter: Marian Hawkey

October 29, 2013

Presentation TCT 2013

Repair vs. Replacement for Functional MR

Presenter: Robert Guyton

October 29, 2013

Advertisement

Slides

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

How Did I Treat This Case?(2)

TCT-71. The Association Between Tissue Characteristics assessed with Optical Coherence Tomography and Midterm Results After Percutaneous Coronary Intervention for In-stent...

SORT-OUT VI: A Prospective, Randomized, All-Comers Trial of Biodegradable Polymer-Coated Biolimus-Eluting Stents vs. Biocompatible Polymer-Coated Zotarolimus-Eluting Coronary...

How Do I Assess Causes of Stent Thrombosis or In-Stent Restenosis?

How Would I Treat This Case?

Case 2: Chronic Total Occulsion (Piedmont Heart Institute, Atlanta, GA)

Case 4: TAVR with Sapien 3 (St. Paul's Hospital/University of British Columbia, Vancouver, Canada)

Repair vs. Replacement for Functional MR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content